Non-alcoholic fatty liver disease: current concepts and management strategies.
about
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitisThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundThe Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and ProgressionSun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic DysfunctionTargeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise LiteratureNew quantitative trait loci for carotid atherosclerosis identified in an intercross derived from apolipoprotein E-deficient mouse strains.Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.Inflammation: The Common Pathway of Stress-Related Diseases.Elevated endotoxin levels in non-alcoholic fatty liver disease.Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital.Vitamin D deficiency in chronic liver disease.Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisResistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight lossChronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice.The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in ratsPrevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control.Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosisBariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver diseaseLow 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.A chat on fat in liverAbnormal glucose tolerance in young male patients with nonalcoholic fatty liver diseaseAssociation between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal eventsNonalcoholic fatty liver disease is associated with coronary artery calcification.Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi-centre, randomised, double-blinded, placebo-controlled trial.Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease.Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.Role of nuclear factor kappaB in liver health and disease.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.Obesity-related cardiorenal disease: the benefits of bariatric surgery.Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease.Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver diseasePhyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH?Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age.Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 diabetic nephropathy rats.
P2860
Q24243033-1803A014-3FDD-4D3C-8E65-66C84B927BD5Q26744380-8D4A3B97-43BB-4E6C-B707-B31F2B5C7890Q26775025-871FE1E9-3331-42F1-95C4-82DCE45053D4Q28073380-E5D6555F-9976-461D-9860-700C81EF577FQ28075794-031ABC9C-D8F3-42DB-869B-6E14C6D39C60Q30413841-EF280A99-66F7-4716-8C8C-91192E099D47Q33308506-F746D49D-2D27-4D8F-8536-804F27F1B441Q33813364-71AE8100-6F31-45BC-8A97-18DCB8264106Q33864406-B24D5C6A-F1F0-49BB-BF11-E4419B483A35Q34005976-E1009543-361D-4FEA-80AD-06E8A03F16EFQ34728285-6FC64DBF-47FB-404B-851E-5248C3DD9215Q35056710-DB59D5E2-BEC9-4258-B069-24A892EAFE24Q35154818-76F807A1-DCA8-47F5-99E1-7034E0EF7C6FQ35597576-E96D05FC-7966-4257-A152-53762E0D0F9AQ35615790-D19262E1-237B-4DD5-A157-8A17EEF79E19Q35753386-24B2161F-834F-4B7A-870D-7253E43D64B6Q35795775-F72FFFF3-9736-4C38-BC25-0A9EA8E97BD0Q36267994-94F37951-855B-4CBE-B36F-99E5E88D31D9Q36334302-926C2FAA-AB14-4C91-AEE4-FB45E06A7109Q36436401-AADD9563-993F-4D9B-A019-B4B4E5398114Q36520423-E552A040-41AF-4E6D-B0B4-1DC087E70A68Q36602895-5BB1640A-9641-45C8-B05E-48EC5FC2101BQ36796750-C267C912-15C0-41D0-AFE3-4269186D3412Q36859567-A8D9DA8C-F6A4-4B97-BE5B-B998A803F6E8Q37138370-39C5E710-A0A6-4826-BF6D-2EDD914408EAQ37263141-0638240E-A6A0-4CAC-879C-F747A053A941Q37282849-FF85AE40-A0C1-468F-8EFC-5C571C93C037Q37316685-0959BABF-1101-407D-BB41-A5D55FAAAD62Q37352458-7F52B9D7-4571-4A2F-BFBC-6464EBF0D786Q37435670-A06E0962-BF55-4B92-8AB6-1F0BC390C878Q37483740-478DE58A-C441-46A5-89B7-3B29086B6D38Q37720780-9CB61594-40BF-4D53-A26F-614F6210FF2AQ37858449-499DD2A1-C53D-448A-9063-CA6484245782Q38126800-090B7119-D4E4-4057-AEC2-4D6A16BFA5C9Q38957194-69AF46D6-70B8-45BD-9917-1C665E88F1F7Q39679120-4EC7637A-CA86-4218-A7B4-9336C40BD867Q41195503-BD083395-8991-43B1-A5DB-EBF3CB8EFBCFQ41278014-A3DC07AE-806A-4119-94F9-B908E1C2E7DDQ42852924-E97959D9-0DAA-466B-A40C-0FED1FD989BCQ42954172-8C854727-03A8-40AA-B129-FEAE566543AF
P2860
Non-alcoholic fatty liver disease: current concepts and management strategies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-alcoholic fatty liver disease: current concepts and management strategies.
@ast
Non-alcoholic fatty liver disease: current concepts and management strategies.
@en
type
label
Non-alcoholic fatty liver disease: current concepts and management strategies.
@ast
Non-alcoholic fatty liver disease: current concepts and management strategies.
@en
prefLabel
Non-alcoholic fatty liver disease: current concepts and management strategies.
@ast
Non-alcoholic fatty liver disease: current concepts and management strategies.
@en
P1433
P1476
Non-alcoholic fatty liver disease: current concepts and management strategies
@en
P2093
Chris P Day
P356
10.7861/CLINMEDICINE.6-1-19
P577
2006-01-01T00:00:00Z